Lido Advisors
TGTX icon

Lido Advisors’s TG Therapeutics TGTX Stock Holding History

Lido Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$589K Buy
17,740
+3,180
+22% +$94.8K ﹤0.01% 1210
2025
Q4 		$516K Buy
14,560
+284
+2% +$9.28K ﹤0.01% 1282
2025
Q3 		$516K Buy
14,276
+541
+4% +$17.8K ﹤0.01% 1220
2025
Q2 		$494K Buy
13,735
+5,837
+74% +$217K ﹤0.01% 1109
2025
Q1 		$311K Buy
7,898
+218
+3% +$7.33K ﹤0.01% 1200
2024
Q4 		$231K Buy
+7,680
New +$220K ﹤0.01% 1322
2021
Q4 		– Sell
-7,785
Closed -$259K – 1046
2021
Q3 		$259K Buy
7,785
+185
+2% +$5.72K 0.01% 800
2021
Q2 		$295K Hold
7,600
– – 0.01% 729
2021
Q1 		$366K Hold
7,600
– – 0.01% 593
2020
Q4 		$395K Hold
7,600
– – 0.01% 541
2020
Q3 		$203K Buy
+7,600
New +$175K 0.01% 588

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return